Avalon GloboCare Collaborates for Cannabis Breathalyzer Development
Company Announcements

Avalon GloboCare Collaborates for Cannabis Breathalyzer Development

An update from Avalon GloboCare ( (ALBT) ) is now available.

Avalon GloboCare Corp. has announced a strategic collaboration with Qi Diagnostics Limited to co-develop a cannabis breathalyzer using VOC nanosensor technology. The collaboration aims to create a prototype capable of real-time detection to aid law enforcement and workplace safety. This initiative emphasizes Avalon’s commitment to innovative diagnostic solutions, although the final agreement hinges on negotiations within a 120-day exclusivity period.

For a thorough assessment of ALBT stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAvalon GloboCare Appoints Dr. Cavo to Advisory Board
TheFlyAvalon appoints Cavto to Scientific Advisory Board
Sheryl ShethUpcoming Stock Splits This Week (October 28 to November 1) – Stay Invested
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App